Uncategorized ‘Breaking the mold with RNA—a “RNAissance” of life science’ – npj Genomic Medicine Read more Beacon maps over 2300 lung cancer biomarkers in new global database – PBI Forum Read more What makes a good antibody–drug conjugate? – Martin De Cecco, Daniel N. Galbraith & Lisa L. McDermottt Read more Beacon Targeted Therapies announces the launch of Beacon Oncolytic Viruses Read more Cell Therapy 2.0 Read more Overcoming Challenges in the Development of Anticancer ADCs Read more Immuno-oncology cell therapies: commercial considerations and strategies for the new decade Read more Beacon Targeted Therapies announces the launch of Beacon Gene Therapy Read more Frontiers in Oncology – Perspective: Designing T-Cell Engagers With Better Therapeutic Windows Read more Hot Topics at CAR-TCR 2020 Read more 1 2 3 Older Posts
What makes a good antibody–drug conjugate? – Martin De Cecco, Daniel N. Galbraith & Lisa L. McDermottt Read more
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade Read more
Frontiers in Oncology – Perspective: Designing T-Cell Engagers With Better Therapeutic Windows Read more
